Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition. Sundararajan V, Ziyu F, Elfar GA, Tan TZ, et al. Oncogene 2026 Jun 11. doi: 10.1038/s41388-026-03830.

Read + Share

Amedeo Smart

Independent Medical Education

Sundararajan V, Ziyu F, Elfar GA, Tan TZ, et al. Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition. Oncogene 2026 Jun 11. doi: 10.1038/s41388-026-03830.
PMID: 42277179